No connection

Search Results

LLY vs PARK

LLY
Eli Lilly and Company
NEUTRAL
Price
$958.65
Market Cap
$858.01B
Sector
Healthcare
AI Confidence
85%
PARK
Park Dental Partners, Inc.
NEUTRAL
Price
$18.02
Market Cap
$81.4M
Sector
Healthcare
AI Confidence
75%

Valuation

P/E Ratio
LLY
41.7
PARK
--
Forward P/E
LLY
22.78
PARK
13.65
P/B Ratio
LLY
32.33
PARK
3.51
P/S Ratio
LLY
13.16
PARK
0.33
EV/EBITDA
LLY
27.08
PARK
11.93

Profitability

Gross Margin
LLY
83.04%
PARK
17.04%
Operating Margin
LLY
44.9%
PARK
-13.4%
Profit Margin
LLY
31.67%
PARK
-0.15%
ROE
LLY
101.16%
PARK
-4.09%
ROA
LLY
19.41%
PARK
0.15%

Growth

Revenue Growth
LLY
42.6%
PARK
7.5%
Earnings Growth
LLY
51.4%
PARK
--

Financial Health

Debt/Equity
LLY
1.65
PARK
2.77
Current Ratio
LLY
1.58
PARK
1.06
Quick Ratio
LLY
0.78
PARK
0.98

Dividends

Dividend Yield
LLY
0.68%
PARK
--
Payout Ratio
LLY
26.14%
PARK
0.0%

AI Verdict

LLY NEUTRAL

LLY shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.

Strengths
Strong profitability (31.7% margin)
Strong revenue growth of 42.6%
Strong ROE of 101.2%
Risks
High valuation with P/E of 41.7
Premium vs Graham Number ($123.85)
Weak financial trend (Piotroski F-Score: 3/9)
PARK NEUTRAL

PARK exhibits a weak fundamental profile, highlighted by a Piotroski F-Score of 3/9, indicating significant financial instability. While the company shows a very attractive Price/Sales ratio (0.33) and a massive recent earnings surprise (+385.7%), these are offset by a high Debt/Equity ratio of 2.77 and negative operating margins. The stock is currently a speculative play where strong analyst price targets ($22.75) clash with poor deterministic health scores. Overall, the valuation is low, but the underlying financial health is precarious.

Strengths
Very low Price/Sales ratio (0.33) suggesting potential undervaluation of revenue
Significant earnings beat in the most recent quarter (+385.7%)
Positive revenue growth (7.5% YoY)
Risks
Weak Piotroski F-Score (3/9) indicating poor financial health
High leverage with a Debt/Equity ratio of 2.77
Negative operating margin (-13.40%) and negative ROE (-4.09%)

Compare Another Pair

LLY vs PARK: Head-to-Head Comparison

This page compares Eli Lilly and Company (LLY) and Park Dental Partners, Inc. (PARK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile